TOBISHI PHARMACEUTICAL CO., LTD.
|TOBISHI PHARMACEUTICAL CO., LTD. Patent applications|
|Patent application number||Title||Published|
|20100247510||AGENT FOR REDUCING A SIDE EFFECT OF AN ANTICANCER DRUG - The present invention provides an agent for reducing a side effect of an anticancer drug, which comprises a thrombin-like enzyme.||09-30-2010|
|20100034803||ACTIVATING AGENT OF STEM CELLS AND/OR PROGENITOR CELLS - The present invention provides an activating agent of stem cells and/or progenitor cells comprising a thrombin-like enzyme which can be used in regenerative medicine, and particularly in regenerative medicine utilizing self-regeneration, acting promptly and moderately depending on the state of advancement and the degree of injured organs and/or tissues to which regenerative medicine is applied, with few or no side effects. The present invention also provides a method for activating stem cells and/or progenitor cells in an animal comprising the step of administering to the animal an effective amount of a thrombin-like enzyme and use of the thrombin-like enzyme for activating stem cells and/or progenitor cells.||02-11-2010|
|20090018062||Malignant tumor-inhibiting preparation comprising des a fibrin - A malignant tumor-inhibiting preparation is provided which comprises Des A fibrin and therefore can inhibit the spreading and migration of malignant tumor cells and thereby can inhibit the malignant tumors.||01-15-2009|
Patent applications by TOBISHI PHARMACEUTICAL CO., LTD.